Bi­par­ti­san bill seeks to tight­en the do­mes­tic phar­ma sup­ply chain

Drug short­ages have sparked hear­ings, ques­tions over why the US doesn’t do more do­mes­tic man­u­fac­tur­ing, and the var­i­ous caus­es. Now, a new bi­par­ti­san Sen­ate bill …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA